Innovative combination of treatments effectively kills acute myeloid leukemia cells

Scientists at VCU Massey Comprehensive Cancer Center have identified an innovative combination of treatment strategies that work collaboratively to effectively kill acute myeloid leukemia (AML) cells, a frequently incurable form of cancer.

EC approves TECVAYLI’s reduced dosage for multiple myeloma

Janssen’s Teclistamab is a bispecific antibody directed at B-cell maturation antigen on multiple myeloma cells. Credit: Vysotsky / commons.wikimedia.org. The European Commission (EC) has approved

August 21, 2023

Evolva Holding AG publishes half-year report 2024 and IFRS annual report 2023 – Biotech Investments

Evolva Holding SA / Key word(s): Annual Results/Half Year Results 29-Oct-2024 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer

October 30, 2024

Do you wear makeup while you exercise? New research reveals the effects on skin and pores

A new study reports the results of an intervention study on skin changes following the use of makeup while exercising on a treadmill.

March 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.